Your shopping cart is currently empty

JNJ-55511118 is a highly efficient and selective TARP γ8 negative allosteric modulator with anticonvulsant and neuroprotective activities. By reducing the peak current of AMPAR containing γ8, it can be used for research on chronic operant alcohol self-administration.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $113 | 35 days | 35 days | |
| 5 mg | $337 | 35 days | 35 days | |
| 10 mg | $613 | 35 days | 35 days | |
| 25 mg | $1,380 | 35 days | 35 days |
| Description | JNJ-55511118 is a highly efficient and selective TARP γ8 negative allosteric modulator with anticonvulsant and neuroprotective activities. By reducing the peak current of AMPAR containing γ8, it can be used for research on chronic operant alcohol self-administration. |
| In vitro | In the competition binding assay, JNJ-55511118 can completely replace the radioligand with a Ki value of 26 nM. [1] |
| Synonyms | JNJ55511118, JNJ 55511118 |
| Molecular Weight | 328.67 |
| Formula | C14H8ClF3N2O2 |
| Cas No. | 2036081-86-2 |
| Smiles | O=C1NC=2C=CC(=CC2N1)C=3C(Cl)=CC=CC3OC(F)(F)F |
| Relative Density. | 1.462 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.